Multi Medika Internasional Tbk. vs Saraswanti Indoland Development Tbk. — how do they compare? Multi Medika Internasional Tbk. trades at Rp760 (market cap 3.72T, 43.61M 24h volume), while Saraswanti Indoland Development Tbk. trades at Rp91 (market cap 500.81B, 1.26M 24h volume). The key difference: Multi Medika Internasional Tbk. is far larger — about 7.4× Saraswanti Indoland Development Tbk.'s market cap, and Multi Medika Internasional Tbk. is more actively traded (43.61M versus 1.26M). Which is the better fit depends on your goals.
| MMIX | SWID | |
|---|---|---|
Market Cap | 3.72T | 500.81B |
Volume | 43.61M | 1.26M |
Lot | 436.07K | 12.61K |
Turnover | 34.14B | 113.99M |
Average Price | 783.01 | 90.38 |
Value | 34.14B | 113.99M |
Indicative Equilibrium Price | 760 | 91 |
Indicative Equilibrium Volume | 3.21K | 643 |
Trailing returns across standard periods
Latest headlines on both assets
PT Multi Medika Internasional Tbk (the Entity) was established based on the Notarial Deed of Ilmiawan Dekrit S., S.H., M.H., No. 23, dated September 28, 2020. The Entity commenced its commercial operations in 2020.
Read more on MMIX →PT Saraswanti Indoland Development Tbk ( The Company) was established on August 2, 2010 based on the Deed of Notary Ismaryani, SH, MKn. Number : 01. The deed of establishment of the Company was approved by the Minister of Law and Human Rights of the Republic of Indonesia number: AHU41610.AH.01.01.Tahun 2010. The Company started its commercial operations in 2011.
Read more on SWID →